The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor.

Gene therapy using non-viral vectors that are safe and efficient in transfecting target cells is an effective approach to overcome the shortcomings of protein delivery of growth factors. The objective of this study was to develop and test a non-viral gene delivery system for bone regeneration utilizing a collagen scaffold to deliver polyethylenimine (PEI)-plasmid DNA (pDNA) [encoding platelet derived growth factor-B (PDGF-B)] complexes. The PEI-pPDGF-B complexes were fabricated at amine (N) to phosphate (P) ratio of 10 and characterized for size, surface charge, and in vitro cytotoxicity and transfection efficacy in human bone marrow stromal cells (BMSCs). The influence of the complex-loaded collagen scaffold on cellular attachment and recruitment was evaluated in vitro using microscopy techniques. The in vivo regenerative capacity of the gene delivery system was assessed in 5 mm diameter critical-sized calvarial defects in Fisher 344 rats. The complexes were ~100 nm in size with a positive surface charge. Complexes prepared at an N/P ratio of 10 displayed low cytotoxicity as assessed by a cell viability assay. Confocal microscopy revealed significant proliferation of BMSCs on complex-loaded collagen scaffolds compared to empty scaffolds. In vivo studies showed significantly higher new bone volume/total volume (BV/TV) % in calvarial defects treated with the complex-activated scaffolds following 4 weeks of implantation (14- and 44-fold higher) when compared to empty defects or empty scaffolds, respectively. Together, these findings suggest that non-viral PDGF-B gene-activated scaffolds are effective for bone regeneration and are an attractive gene delivery system with significant potential for clinical translation.

[1]  J. Veerkamp,et al.  Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. , 2002, Journal of biomedical materials research.

[2]  K. Mechtler,et al.  Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. , 1996, Human gene therapy.

[3]  I. Papisov,et al.  Molecular “recognition” in interpolymer interactions and matrix polymerization , 1989 .

[4]  Hasan Uludağ,et al.  Effects of size and topology of DNA molecules on intracellular delivery with non-viral gene carriers , 2008, BMC biotechnology.

[5]  C. Evans,et al.  Gene delivery to bone. , 2012, Advanced drug delivery reviews.

[6]  E. Sage,et al.  PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors , 1994, The Journal of cell biology.

[7]  A. Mikos,et al.  Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency , 1999, Gene Therapy.

[8]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  M. F. Fuller,et al.  Practical Nonparametric Statistics; Nonparametric Statistical Inference , 1973 .

[10]  A. Mikos,et al.  Poly(ethylenimine) and its role in gene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[11]  H. Antoniades,et al.  A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. , 1989, Journal of clinical periodontology.

[12]  J. Persing,et al.  Repair of critical size rat calvarial defects using extracellular matrix protein gels. , 1995, Journal of neurosurgery.

[13]  S. Lynch,et al.  Recombinant human platelet-derived growth factor: biology and clinical applications. , 2008, The Journal of bone and joint surgery. American volume.

[14]  E. Canalis,et al.  Growth factors and the regulation of bone remodeling. , 1988, The Journal of clinical investigation.

[15]  Steven A. Goldstein,et al.  PDGF-B Gene Therapy Accelerates Bone Engineering and Oral Implant Osseointegration , 2009, Gene Therapy.

[16]  G. Gillies,et al.  Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. , 1997, Journal of neurosurgery.

[17]  David J Mooney,et al.  Fabrication and in vitro testing of polymeric delivery system for condensed DNA. , 2003, Journal of biomedical materials research. Part A.

[18]  Q. Jin,et al.  Gene therapeutics for periodontal regenerative medicine. , 2006, Dental clinics of North America.

[19]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Antonios G. Mikos,et al.  Pore Morphology Effects on the Fibrovascular Tissue Growth in Porous Polymer Substrates , 1994, Cell transplantation.

[21]  B. Baum,et al.  Gene Therapy: Some History, Applications, Problems, and Prospects , 2008, Toxicologic pathology.

[22]  David J. Mooney,et al.  Tissue engineering using synthetic extracellular matrices , 1996, Nature Medicine.

[23]  L. Monaco,et al.  Nanoscopic structure of DNA condensed for gene delivery. , 1997, Nucleic acids research.

[24]  M. Cotten,et al.  Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Javed,et al.  Significance of the platelet-derived growth factor in periodontal tissue regeneration. , 2011, Archives of oral biology.

[26]  A. Mikos,et al.  Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.

[27]  D. Mooney,et al.  Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) , 2005, Gene Therapy.

[28]  R. A. Groeneveld,et al.  Practical Nonparametric Statistics (2nd ed). , 1981 .

[29]  S. Elangovan,et al.  Review Paper: DNA Delivery Strategies to Promote Periodontal Regeneration , 2010, Journal of biomaterials applications.

[30]  C. Sfeir,et al.  Gene therapy approaches for modulating bone regeneration. , 2000, Advanced drug delivery reviews.

[31]  W. Gu,et al.  Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. , 1994, Science.

[32]  J. C. Perales,et al.  Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. , 1995, The Journal of clinical investigation.

[33]  M. Merchant,et al.  Therapeutic angiogenesis due to balanced single‐vector delivery of VEGF and PDGF‐BB , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  M. Nango,et al.  The fusogenic effect of synthetic polycations on negatively charged lipid bilayers. , 1986, Journal of biochemistry.

[35]  S. Goldstein,et al.  Potential Role for Direct Gene Transfer in the Enhancement of Fracture Healing , 1998, Clinical orthopaedics and related research.

[36]  S. Ferrari,et al.  ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo , 1997, Gene Therapy.

[37]  K. Yoshikawa,et al.  Direct observation of the biphasic conformational change of DNA induced by cationic polymers , 1991, FEBS letters.

[38]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Colvin,et al.  Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. , 1989, The Journal of clinical investigation.

[40]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[41]  A Daluiski,et al.  The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.

[42]  Vishal Kapoor,et al.  Contribution of Bone Marrow–Derived Cells to Skin: Collagen Deposition and Wound Repair , 2004, Stem cells.

[43]  D J Mooney,et al.  Development of biocompatible synthetic extracellular matrices for tissue engineering. , 1998, Trends in biotechnology.

[44]  A. Salem,et al.  Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Tae Gwan Park,et al.  Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. , 2007, Advanced drug delivery reviews.

[46]  Grey Giddins,et al.  Statistics , 2016, The Journal of hand surgery, European volume.

[47]  Y. M. Lee,et al.  The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. , 2000, Journal of periodontology.

[48]  T. Bettinger,et al.  Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. , 1999, Bioconjugate chemistry.

[49]  S. Lynch,et al.  Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. , 2003, Journal of periodontology.

[50]  C. Benoist,et al.  A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. , 1996, Human gene therapy.

[51]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates. , 1995, Human gene therapy.

[52]  E. Schacht,et al.  Synthetic polymers for vectorial delivery of DNA : characterisation of polymer-DNA complexes by photon correlation spectroscopy and stability to nuclease degradation and disruption by polyanions in vitro , 1997 .

[53]  F. Silver,et al.  Effects of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices. , 1991, Journal of biomedical materials research.

[54]  H. Leonhardt,et al.  Reversal of terminal differentiation and control of DNA replication: Cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication , 1993, Cell.